Ouabain effects on oxygen physiology in anemic lambs

Area of Science:

• Cardiovascular Physiology
• Neonatal Research
• Pharmacology

Background:

• Anemia significantly impacts cardiac function and oxygen delivery.
• Ouabain is a cardiac glycoside used to treat heart failure, but its effects in neonatal anemia are not well understood.

Purpose of the Study:

• To investigate the effects of anemia and ouabain on cardiac function, oxygen physiology, and catecholamine levels in newborn lambs.
• To differentiate ouabain's impact on contractility versus oxygen transport in anemic neonates.

Main Methods:

• Continuous measurement of oxygen consumption and hemodynamic variables in nine newborn lambs.
• Induction of moderate anemia (hematocrit 12%) via isovolemic exchange transfusion.
• Administration of ouabain (bolus and infusion) with repeated physiological measurements.

Main Results:

• Anemia increased heart rate, cardiac output, oxygen consumption, and fractional oxygen extraction, while decreasing systemic vascular resistance.
• Ouabain administration led to decreased cardiac output, oxygen consumption, and stroke work, without altering left ventricular pressure rise or extraction ratio.
• Epinephrine and norepinephrine levels increased with sustained anemia and ouabain infusion.

Conclusions:

• In newborn lambs with anemia, ouabain primarily affects oxygen transport and metabolism.
• Ouabain's effects in this context are not primarily mediated by changes in traditional measures of left ventricular contractile function.
• Findings highlight the complex interplay between anemia, cardiac function, and pharmacologic intervention in neonates.